baber/WOPTO huggingface dataset:
Patent EP-3941148-A1 (EP)
Title: Communication method, device and equipment
Inventor: YANG SHUIGEN
IPC: H04W74/00
Filed: 2020-03-11
Abstract: Embodiments of this application provide a communication method, a communication apparatus, and a device. The method includes: A network device receives first information sent by a terminal device, where the first information is information about a two-step random access process of the terminal device; and the network device updates a random access configuration based on the first information. Communication reliability is improved.
Patent EP-3953727-A1 (EP)
Inventor: HAREL RAPHAEL
IPC: G01S7/484
Filed: 2020-04-06
Abstract: A solid state LIDAR transmitter with matrix-addressable laser drive circuit includes a first electrical bus that provides a first voltage potential to columns of the matrix-addressable laser drive circuit and a second electrical bus that provide a second voltage potential to rows of the matrix-addressable laser drive circuit. A plurality of column switches connects the plurality of columns to the first electrical bus. A plurality of row switches connects the plurality of rows to the second electrical bus. The transmitter includes a plurality of series connected diodes comprising a laser diode in series with another diode, where a respective one of the plurality of series connected diodes is electrically connected between a respective column and row of the matrix-addressable laser drive circuit to form the LIDAR transmitter. At least some of the second diodes increasing an overall reverse breakdown voltage of the series connected diodes.
Patent EP-3954139-A1 (EP)
Inventor: ROGERS GARETT
IPC: G06Q50/12
Filed: 2020-04-13
Abstract: : A method of processing orders and payments in a location-based food-service venue such as a restaurant, stadium or arena. Each customer location has a physical identity target attached in proximity thereto comprising a unique system-wide identifier readable by customer mobile devices. Targets might be visually readable, using QR codes or the like, or might be a short range radio beacon broadcasting the identifier (NFC, RFID etc.) – they do not contain human-readable location indication information. The identifiers associated with the targets do not contain location- or venue-specific information, and are recorded in relation to location records corresponding to individual customer locations in the venue in a order database held on a server. On reading of a target by a customer device and a related location transmission to a server, the server can associate the transmission with its related customer location in the venue-associated POS system, facilitate a selection of items for ordering regarding the location and facilitate an ordering transaction for the amount owing at the selected customer location through a transaction gateway, and provide a transaction completion indication to the POS system. The method allows for enhanced velocity in deployment and maintenance of location targets, and enables mobile device-based ordering and payment in venues previously not offering same. Systems and software are also disclosed.
Patent EP-4045651-A1 (EP)
Inventor: VAGHCHHIPAWALA ZARIR
IPC: C12N15/113
Filed: 2020-10-14
Abstract: La présente invention concerne une nucléase de type MAD7, ayant été modifiée pour reconnaître un PAM choisi parmi TYCV, TATV ou TTCN. L'invention concerne des séquences codant ou représentant une nucléase de type MAD7 portant certaines mutations par rapport à la séquence d'une nucléase MAD7. L'invention concerne également un système d'ingénierie génomique, une construction d'expression et un kit comprenant une nucléase de type MAD7 selon l'invention. De plus, l'invention concerne un procédé de modification ciblée d'au moins une séquence cible génomique dans une cellule, comprenant l'introduction de la nucléase de type MAD7 selon l'invention dans la cellule. L'invention concerne également une cellule et un organisme obtenus par un procédé selon l'invention.
Patent EP-4041890-A1 (EP)
Title: Antisense oligonucleotides and their use for the treatment of pain
Inventor: VENTEO STÉPHANIE
IPC: A61P43/00
Filed: 2020-10-09
Abstract: The invention relates to an inhibitor of FXYD2 wherein said inhibitor reduces the expression and/or activity of FXYD2 in a subject in need thereof and targets at least the region comprising or consisting of the nucleotides 219-229 of SEQ ID NO: 3. Inventors have shown that targeting a region of FXYD2 can be used to inhibit and/or reduce the expression and/or activity of FXYD2. They have designed and synthesized an antisense oligonucleotide (SEQ ID NO: 4) targeting the rat and human FXYD2 gene. The have performed intrathecal injection of FXYD2 optimized ASO in two rat models of pain (neuropathic and inflammatory pain). They have shown that FXYD2 ASO efficiently reduces its expression in rat Dorsal root ganglion (DRG). The have demonstrated that FXYD2 ASO dramatically reduces neuropathic pain in the Spinal Nerve Ligation (SNL) rat model and analgesic effect of FXYD2 ASO on neuropathic pain is greater than that of Ziconotide, the current market leader. They also have shown that FXYD2 ASO dramatically reduces inflammatory pain in Complete Freund's Adjuvant (CFA)-induced rat model.
Patent EP-3966741-A1 (EP)
Title: Method and system for initializing a neural network
Inventor: VARNO FARSHEED
IPC: G06N3/08
Filed: 2020-05-07
Abstract: A method and a system are disclosed for initializing a pre-trained neural network, the method comprising obtaining a pre-trained neural network having an output layer, amending the output layer of the pre-trained neural network, wherein the amending comprises updating each weight of the output layer according to a function that maximizes the entropy of the output classes probability, wherein the function depends on a parameter controlling a proportion of error of the output classes probability such as it decreases the variance of the output classes probability, and providing the initialized pre-trained neural network.
Patent EP-4058113-A1 (EP)
Title: Baume de soin de la peau et dispositif pour application nasale interne et externe
Inventor: PAPAFRAGHA MATINA
IPC: A61M15/00
Filed: 2020-11-12
Abstract: L'invention concerne un baume de soin de la peau comprenant de 15 % à 45 % (poids/poids) d'au moins deux cires, une première cire ayant un point de fusion de 70 °C à 90 °C et une seconde cire ayant un point de fusion de 30 °C à 60 °C, le baume comprenant en outre de 45 % à 70 % (poids/poids) d'un émollient et d'un agent apaisant la peau. Le baume pour le soin de la peau peut être appliqué sur la peau dans la zone périnasale. L'invention concerne également un produit de combinaison comprenant un baume de soin de la peau et un produit de pulvérisation nasale.
Patent EP-4049138-A1 (EP)
Inventor: GOODWIN ROBERT LOVEJOY
IPC: G06F9/50
Filed: 2020-10-16
Abstract: A technique is described herein that intelligently deploys resources in a data center for a new program. The new program has, at least in part, unknown runtime characteristics. The technique involves collecting plural input factors that provide evidence of an expected runtime behavior of the new program. It does so by identifying at least one related program that differs from the new program, but has a specified degree of relatedness to the new program. The collecting operation then obtains information that describes an amount of resources that the related program(s) consume when run. Based on at least some of the plural input factors, the technique generates an estimated amount of resources that the new program is expected to consume when it is run. The technique then determines and deploys a configuration of resources in the data center that will provide the estimated amount of resources.
Patent EP-4049346-A1 (EP)
Inventor: MESSER MICHAEL
IPC: G01R1/04
Filed: 2020-10-21
Abstract: Die Erfindung bezieht sich auf eine Kontaktiereinrichtung (3) zur temporären elektrischen Kontaktierung eines ersten Kabelabschnittes (5) eines Kabels (20), insbesondere eines ersten Kabelendes, an einer Kabelprüfvorrichtung (10), wobei die Kontaktiereinrichtung (3) eine Aufnahme (4) zum Aufnehmen des ersten Kabelabschnittes (5) und ein im Bereich der Aufnahme (4) angeordnetes erstes Kontaktelement (1) zur Herstellung eines ersten elektrischen Kontaktes zu einem in der Aufnahme (4) befindlichen ersten Kabelabschnitt (5) aufweist, dadurch gekennzeichnet, dass die Kontaktiereinrichtung (3) ein im Bereich der Aufnahme (4) angeordnetes zweites Kontaktelement (2) zur Herstellung eines zweiten elektrischen Kontaktes zu einem in der Aufnahme (4) befindlichen ersten Kabelabschnitt (5) aufweist, wobei die Aufnahme (4) zylinderförmig ist und wobei das erste Kontaktelement (1) und/oder das zweite Kontaktelement (2) mit einer Leuchteinrichtung (9), insbesondere in Form einer Leuchtdiode, zur Anzeige des Kontaktierungszustandes elektrisch verbunden ist/sind.
Patent EP-4241398-A1 (EP)
Inventor: ALMLOF JONAS
IPC: H04B10/70
Filed: 2020-11-09
Abstract: Examples of this disclosure include a method of detecting or correcting one or more errors in data. The method comprises receiving data in a channel, wherein the datacomprises one or more symbols, wherein each symbol corresponds to one of a ground state or to one of one or more energized states, and wherein the only transition possible for a symbol in the channel is one in which one of the one or more energized states transitions to the ground state, and wherein the data comprises at least one symbol that corresponds to the ground state. The method also comprises analyzing the one or more symbols to determine if a transition of one or more of the states has occurred and, if a transition of one or more of the states has occurred, detecting or correcting errors in the data.
Patent EP-4062170-A1 (EP)
Inventor: SÖRBY LENNART
IPC: G01N30/82
Filed: 2020-11-19
Abstract: The present invention relates to a method for controlling fraction collection of a target product 27 in a chromatography system 49 configured for cyclic purification performed on a sample comprising the target product 27. The method comprises determining trigger points for target product 27 collection in relation to presence of target product in the outlet; setting a first time period based on the trigger points within which the elution in the first cycle is captured; evaluating timing of the captured elution to identify the next time period; applying the timing to capture elution during the elution phase in the following cycle; and collecting the captured elution in the following cycle. The last three steps are repeated to capture the elution during the elution phase of the following cycles until no more target product 27 is desired.
Patent EP-3976618-A1 (EP)
Inventor: VENDEVILLE SANDRINE
IPC: A61P31/12
Filed: 2020-05-27
Abstract: L'invention concerne des composés de formule (I), ou des sels pharmaceutiquement acceptables de ceux-ci, des compositions pharmaceutiques qui comprennent un composé décrit ici (comprenant des sels pharmaceutiquement acceptables d'un composé décrit ici) et des procédés de synthèse de ceux-ci. L'invention concerne également des procédés de traitement de maladies et/ou d'états avec un composé de formule (I), ou un sel pharmaceutiquement acceptable de celui-ci.
Patent EP-3979619-A1 (EP)
Inventor: You Honghao
IPC: H04M1/725
Filed: 2020-05-26
Abstract: The present disclosure provides a video recording method and a terminal, where the method is applied to a terminal including a rotatable camera and includes: receiving a first input performed by a user for N feature images; recording M target to-be-recorded objects in response to the first input, where the N feature images include the M target to-be-recorded objects; and controlling a camera to rotate, recording the M target to-be-recorded objects, and outputting a target video; where M is less than or equal to N.
Patent EP-3976660-A1 (EP)
Inventor: TANG LEYAN
IPC: A61K39/00
Filed: 2020-05-27
Abstract: Provided are antibodies that specifically recognize B7 homology 3 protein (B7-H3).
Patent EP-3976109-A1 (EP)
Title: Photoactivated blood products and methods and apparatus for fabrication and use of same
Inventor: MEDENDORP JR NICHOLAS WILLIAM
IPC: A61K41/17
Filed: 2020-05-22
Abstract: Embodiments provide methods and apparatus for fabricating blood products, such as platelet-rich plasma, containing elevated concentrations of growth factors such as platelet derived growth factor. The platelet-rich plasma can be autologous, and the concentration of growth factors (e.g., platelet derived growth factor) is elevated relative to other samples isolated from the same subject. The platelet-rich plasma can be used to promote tissue regeneration, including wound healing, joint repair, hair growth, and the like. The compositions can be combined with stem cells and used to treat disorders otherwise treated with stem cells. The growth factors present in the samples can direct the differentiation of the stem cells.
Patent EP-3978532-A1 (EP)
Inventor: TAN YONGCONG
IPC: C07K16/30
Filed: 2020-05-21
Abstract: Disclosed is a novel CLDN18.2 binding molecule. Also disclosed are a nucleic acid molecule encoding the CLDN18.2 binding molecule, an expression vector and a host cell for expressing the CLDN18.2 binding molecule. Further disclosed are a method for producing the CLDN18.2 binding molecule and use thereof.
Patent EP-4061355-A1 (EP)
Inventor: KOTAMRAJU SRIGIRIDHAR
IPC: A61P17/02
Filed: 2020-11-23
Abstract: The present invention relates to the use of a compound of Formula (I) for the treatment of a wound, impaired healing of a wound, hair loss on and around a wound, scars and/or wrinkles on and around a wound, psoriasis, and any combination thereof. The present inventions also relates to methods of using such compounds, and to compositions and kits containing the compound. (I) X -  is any halogen.
Patent EP-3963885-A1 (EP)
Inventor: DENG ZHIPIN
IPC: H04N19/176
Filed: 2020-06-05
Abstract: Devices, systems and methods for digital video coding, which includes matrix-based intra prediction methods for video coding, are described. In a representative aspect, a method for video processing includes performing a first determination whether a luma video block of a video is coded using a matrix based intra prediction (MIP) mode; performing a second determination that the luma video block is applicable for determining a chroma intra mode for a current chroma video block of the video; performing, based on the first determination and the second determination, a third determination about the chroma intra mode to be used for the current chroma video block; and performing, based on the third determination, a conversion between the current chroma video block and a bitstream representation of the current chroma video block.
Patent EP-4244218-A1 (EP)
Title: 1-(2-(4-cyclopropyl-1h-1,2,3-triazol-1-yl)acetyl)-4-hydroxy-n-(benzyl)pyrrolidin e-2-carboxamide derivatives as vhl inhibitors for the treatment of anemia and cancer
Inventor: FUHRMANN JAKOB
IPC: C07D403/06
Filed: 2020-11-30
Abstract: The present disclosure relates to 1-(2-(4-cyclopropyl-1H-l,2,3- triazol-l-yl)acetyl)-4-hydroxy-N-(benzyl)pyrrolidine-2-carboxamide derivatives and structurally related compounds as VHL inhibitors for the treatment of e.g. anemia (e.g. chronic anemia or anemia associated with chronic kidney disease, dialysis or cancer chemotherapy), ischemia, stroke or damage to the cardiovascular system during ischemia, or for enhancing wound healing, reducing scarring, or enhancing angiogenesis or arteriogenesis, and cancer. Exemplary compounds are e.g.: N-(3-([l,l'-biphenyl]-4-yl)-l-amino-l-oxopropan-2-yl)-l-(2- (4-cyclopropyl-lH-l,2,3-triazol-l-yl)-3-methylbutanoyl)-4- hydroxypyrrolidine-2-carboxamide; N-(3-([l,l'-biphenyl]-4-yl)-l-amino-l-oxopropan-2-yl)-l-(2-(4- cyclopropyl-lH-l,2,3-triazol-l-yl)propanoyl)-4-hydroxypyrrolidine-2- carboxamide; N-(3-([1,1'-biphenyl]-4-yl)-l-amino-l-oxopropan-2-yl)-1-(2- (4-cyclopropyl-1H-l,2,3-triazol-l-yl)-3,3-dimethylbutanoyl)-4- hydroxypyrrolidine-2-carboxamide; N-(3-([1,1'-biphenyl]-4-yl)-l-amino-1-oxopropan-2-yl)-1-(2-cyclobutyl-2- (4-cyclopropyl-1H-1,2,3-triazol-l-yl)acetyl)-4-hydroxypyrrolidine-2- carboxamide; 1-(2-(4-cyclopropyl-1H-1,2,3-triazol-1-yl)-3,3-dimethylbutanoyl)-4- hydroxy-N-(1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2- carboxamide; 1-(2-cyclohexyl-2-(4-cyclopropyl-1H-1,2,3-triazol-l-yl)acetyl)-4- hydroxy-N-(1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2- carboxamide; 1-(2-(adamantan-1-yl)-2-(4-cyclopropyl-1H-1,2,3-triazol-l-yl)acetyl) -4-hydroxy-N-(1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2- carboxamide; l-(2-(4-cyclopropyl-lH-l,2,3-triazol-l-yl)-3,3-dimethylpentanoyl)-4- hydroxy-N-(l-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2- carboxamide.
Patent EP-3983077-A1 (EP)
Inventor: NAIR JAYAPRAKASH K
IPC: A61P25/28
Filed: 2020-06-16
Abstract: One aspect of the present invention relates to a double stranded iRNA agent comprising an antisense strand which is complementary to a target gene; a sense strand which is complementary to said antisense strand; and one or more lipophilic moieties conjugated to one or more internal positions on at least one strand, optionally via a linker or carrier, which provides for targeting to, and uptake by, tissues and cells of the CNS, and in particular the striatum. Another aspect of the invention relates to a method of gene silencing in tissues and cells of the CNS, and in particular the striatum, that includes administering to a tissue/cell or a subject in need thereof a therapeutically effective amount of the lipophilic moieties-conjugated double-stranded iRNAs.
Patent EP-4077408-A1 (EP)
Inventor: MARKEL ERIC J
IPC: C08F2/34
Filed: 2020-11-23
Abstract: Ethylene, alpha olefins, and other olefinically unsaturated monomers may be polymerized under fluidized bed polymerization reaction conditions in the presence of a Ziegler-Natta catalyst. A recycle stream featuring an induced condensing agent (ICA) comprising isobutane may increase catalyst productivity while maintaining quality of the polymer product, particularly when the recycle stream is delivered to a reactor containing the fluidized bed under conditions suitable to form a condensed or super-condensed mode in the recycle stream. The recycle stream may comprise unreacted olefinic monomers, and isobutane or a mixture of isobutane and isopentane.
Patent EP-4009817-A1 (EP)
Title: Compact pipe for smoking cannabis
Inventor: BARENBOYM MICHAEL
IPC: A24F1/00
Filed: 2020-07-29
Abstract: A compact smoking pipe 100 for smoking cannabis features an elongated smoke pathway 158' prior to entering the mouthpiece 102 so as to cause smoke cooling and purification by removal of smoking debris along the convoluted smoking pathway 158'. An elongated serpentine groove 158 is formed on the exterior of an elastic stem insert 150 configured for insertion into a rigid outer shell 130 during the pipe assembly. Elastic stem insert 150 also serves to brush off smoke stains and deposits of smoke debris from the inside of the outer shell 130, making cleaning of the pipe easy and convenient. A smoke chamber 165 is formed below the cannabis container 190 in a pipe bowl 160 to cause even distribution of air and smoke flow throughout the volume of cannabis to eliminate the need to frequently light up the smoking pipe 100 during use.
Patent EP-4013010-A1 (EP)
Inventor: KIM HYUNSOOK
IPC: H04W68/00
Filed: 2020-04-16
Abstract: One disclosure of the present specification provides a communication method related to a change of an application server performed by an SMF node. The method may comprise: a step for transmitting a notification message related to a change of a user plane path to an AF node; a step for receiving a response message from the AF node in response to the notification message; and a step for transmitting a message including information on an IP address of the changed application server to a terminal through an AMF node.
Patent EP-4013423-A1 (EP)
Title: In-situ gel forming ophthalmic formulations containing difluprednate
Inventor: LIANG BO
IPC: A61K47/36
Filed: 2020-08-18
Abstract: The present invention provides aqueous in-situ gel ophthalmic formulations, each including water, difluprednate and a biocompatible polysaccharide, wherein a gel is formed in situ at physiological temperature with instant viscosity increase upon instillation of the formulation into an eye. In the formulations, nanocarriers may be formed by a surfactant or solubilizer contained in the formulation, with or encapsulating difluprednate, and the nanocarriers have an average particle size of 10 to 500 nm or 10 to 150 nm or 10-to 50 nm..
Patent EP-3881530-A1 (EP)
Inventor: ZHAO LIANG
IPC: H04N19/12
Filed: 2020-08-20
Abstract: A method of video decoding can include determining a prediction mode of a current coding unit (CU), and determining values of a transform unit (TU) coded block flag (CBF) of a Cb transform block, denoted tu_cbf_cb, and a TU CBF of a Cr transform block, denoted tu_cbf_cr, determining a context index, denoted ctxIdx, based on the prediction mode of the current CU and the values of the tu_cbf_cb, and the tu_cbf_cr, and performing an arithmetic decoding process according to a context model indicated by the ctxIdx to determine a bin of a joint Cb Cr residual (JCCR) flag indicating whether residual samples for both Cb and Cr chroma components of the current CU are coded as a single transform block.
Patent EP-4031520-A1 (EP)
Title: Imaging and therapeutic compositions
Inventor: DONNELLY PAUL STEPHEN
IPC: A61P35/00
Filed: 2020-09-18
Abstract: The invention discussed in this application relates to hydroxamic acid-based compounds that are useful as imaging and therapeutic agents when bound to an appropriate metal centre, particularly for the imaging of tumours.
Patent EP-4012748-A1 (EP)
Inventor: BIMURZAEV SEITKERIM BIMURZAEVICH
IPC: H01J49/40
Filed: 2020-01-20
Abstract: The invention refers to the field of mass spectrometry with orthogonal injection of ions and can be used in solving problems of organic and bioorganic chemistry, immunology, biotechnology and medicine in the ionization of test substances by electron impact, "electrospray" and other methods. 
     The time-of-flight mass spectrometer consists of an ion source of the "electrospray" type, an orthogonal ion accelerator (pulser), including the areas of accumulation and acceleration of ions, a field-free flight space, an electrostatic mirror and a detector. The pulser acceleration area is formed by three gridless electrodes, made of a pair of parallel plates separated by straight gaps and creating an inhomogeneous electrostatic field of two-dimensional symmetry; the electrostatic mirror is also formed by three gridless electrodes, made of a pair of parallel plates separated by annular gaps and creating an inhomogeneous electrostatic field of transaxial symmetry. 
     The advantage of the invention is high sensitivity of the device.
Patent EP-4037324-A1 (EP)
Inventor: GAO XINWEI
IPC: H04N21/234
Filed: 2020-09-08
Abstract: A video processing method, comprising: determining at least a pair of decoding blocks to be reconstructed from a current decoded video frame to be processed, each pair of decoding blocks in the at least a pair of decoding blocks comprising a first decoding block of a first resolution and a second decoding block of a second resolution; adjusting the first resolution of the first decoding block to a target resolution, and adjusting the second resolution of the second decoding block to the target resolution; determining a first edge pixel set from the first decoding block, and determining a second edge pixel set from the second decoding block; and performing filtering processing on the first edge pixel set to obtain a filtered first edge pixel set, and performing filtering processing on the second edge pixel set to obtain a filtered second edge pixel set.
Patent EP-4006220-A1 (EP)
Title: Multilayer fabric
Inventor: HEO JIN WOOK
IPC: D03D1/02
Filed: 2020-09-28
Abstract: The present disclosure relates to a multi-layer fabric, and an airbag formed of the multi-layer fabric. The multi-layer fabric can provide an airbag capable of sufficiently protecting a driver or a passenger by minimizing damage caused by broken glass fragments when a vehicle is overturned.